Sponsors
The bill increases transparency and enforcement to curb profit‑driven practices and protect federal program integrity, but at the cost of substantial compliance, tax, and financing impacts that could raise provider costs, create legal uncertainty, and risk unintended penalties or privacy exposures.
State attorneys general, patients, and the public: stronger enforcement tools (AG authority, criminal penalties, multiplied civil penalties, and improved disclosures) increase accountability, deter profit‑driven conduct that harms patients, and enable recovery of funds for harmed communities and employee benefits.
Hospitals, health systems, and providers: the bill preserves access to federal program payments by restricting transfers/encumbrances to REITs (with safe harbors for pre-enactment agreements), reducing the ability to shift assets away from provider operations and stabilizing program funding.
Patients, payers, and regulators: required public reporting of ownership, control, and value‑based payment information increases transparency, helping consumers and payers choose providers, enabling regulators to detect consolidation/conflicts of interest, and improving evaluation of quality‑payment impacts.
Millions of patients and taxpayers: increased penalties, reporting requirements, tax changes, and restrictions on REIT transactions could raise providers' financing and compliance costs, strain provider finances, and be passed through as higher health care prices or reduced access to services.
Hospitals, owners, investors, and borrowers: legal uncertainty and transition burdens (transactions near enactment, taxable year changes, and the Paperwork Reduction Act exemption) may prompt delays, litigation, and increased planning or compliance costs.
Covered executives and managers: criminal exposure tied to corporate outcomes (even where causation is complex) risks prosecutions or deterrence of leadership decisions, potentially chilling management and investment in care innovations.
Based on analysis of 7 sections of legislative text.
Creates criminal/civil clawbacks for corporate conduct that harms patients, mandates broad public reporting by health entities, changes REIT/tax rules, and orders an HHS OIG study.
Introduced February 12, 2026 by Maggie Goodlander · Last progress February 12, 2026
Creates new criminal, civil, and clawback rules to hold executives and related parties at health-care corporations responsible when corporate actions (like bankruptcy, asset sales, or other “triggering events”) harm patients or cause death; allows federal and state attorneys general to recover compensation from those parties and puts recovered money into a fund for affected workers and communities. It also changes tax and REIT rules that affect health-care property and investment returns, removes REIT-qualified dividends from the QBI deduction, requires broad annual public ownership and financial reporting for covered health entities beginning in 2027, and directs an HHS Inspector General study on profit-driven practices in health care and their effects.